New Drug Discovery – Putting Patients First – Asrar Qureshi’s Blog Post #1304

Asrar Qureshi’s Blog Post #1304 highlights Astellas Pharma’s innovative approach to drug development, emphasizing patient-centric decision-making. The company shifts from traditional therapeutic areas to a model based on biology, modality, and disease. Astellas champions learning from failures, cross-functional teams, and harnessing automation to enhance patient outcomes and operational efficiency.
Share
View Post

The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 2 – Asrar Qureshi’s Blog Post #1292

This blog post by Asrar Qureshi examines the exit of multinational pharmaceutical companies from Pakistan, analyzing its historical context and impacts on the healthcare system. While local firms maintain medicine availability, concerns arise regarding innovation and clinical research. The challenge remains to balance local manufacturing capabilities with the need for multinational investment and research.
Share
View Post

Putting Patient Care First – Asrar Qureshi’s Blog Post #1120

In healthcare, patient care must be prioritized above profit-driven motives, as emphasized by Drew Ungerman from McKinsey. Effective systems should focus on improving patient experiences, shifting from “sick care” to “health care.” Innovations should enhance access and reduce disparities, ensuring care is human-centered, dignified, and empathetic.
Share
View Post

Pharma & the Future: Powered by Partnership & Patient Experience – Asrar Qureshi’s Blog Post 993

This blogpost provides a summary of a new Whitepaper on patient engagement within the pharmaceutical industry. It discusses the shift towards prioritizing patients, driven by global and local initiatives, and the challenges and opportunities in measuring the impact of patient engagement. It also highlights the importance of strategic partnerships and technology in driving the industry’s future success.
Share